Inactive Instrument

Immunosyn Corp Stock

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	08-07-16	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	08-05-16	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	08-03-31	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	08-02-26	PR
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	08-02-01	PR

Managers	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	73	07-10-14
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Members of the board	Title	Age	Since
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	07-10-14

Sector

	1st Jan change	Capi.
CSL LIMITED	+7.87%	100B
SAMSUNG BIOLOGICS CO.,LTD.	+8.42%	42.34B
BIOGEN INC.	-13.04%	32.76B
UCB	+80.80%	29.46B
BIOMARIN PHARMACEUTICAL INC.	-10.92%	16.31B
INCYTE CORPORATION	+1.93%	14.39B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-6.77%	12.23B
ALTEOGEN INC.	+177.16%	10.47B
SWEDISH ORPHAN BIOVITRUM AB	+4.12%	8.97B